Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ TMEM106B Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5100353

Catalog No. PIPA5100353


Only null left
Add to Cart

Description

Description

Antibody detects endogenous levels of total TMEM106B.

Transmembrane protein 106B (TMEM106B) is a single-pass transmembrane protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual role of TMEM106B, and that of the closely related protein TMEM106A are still undetermined.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TMEM106B
Polyclonal
Unconjugated
TMEM106B
2310036D22Rik; 5830455K21Rik; 6430519M21Rik; AI428776; AI661344; hypothetical protein LOC508903; LRRGT00101; tmem106b; tmem106bb; Transmembrane protein 106B; transmembrane protein 106Bb; zgc:114147
Rabbit
Affinity chromatography
RUO
54664, 71900
-20°C
Liquid
Western Blot
1 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Q80X71, Q9NUM4
TMEM106B
A synthesized peptide derived from human TMEM106B(Accession Q9NUM4), corresponding to amino acid residues V45-K95.
100 μL
Primary
Human, Mouse
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.